These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 19406341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Sarno G, Lagerqvist B, Fröbert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S.
    Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A, ISAR-DIABETES Study Investigators.
    N Engl J Med; 2005 Aug 18; 353(7):663-70. PubMed ID: 16105990
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y, Iijima R, Shiba M, Nakamura M, Sugi K.
    J Cardiol; 2010 May 18; 55(3):391-6. PubMed ID: 20350511
    [Abstract] [Full Text] [Related]

  • 10. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M, Pasquet A, Preumont V, Kefer J, Hermans MP, Vanoverschelde JL, Buysschaert M.
    Diabetes Metab; 2008 Feb 18; 34(1):62-7. PubMed ID: 18069029
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Tomai F, Reimers B, De Luca L, Galassi AR, Gaspardone A, Ghini AS, Ferrero V, Favero L, Gioffrè G, Prati F, Tamburino C, Ribichini F.
    Diabetes Care; 2008 Jan 18; 31(1):15-9. PubMed ID: 17909090
    [Abstract] [Full Text] [Related]

  • 16. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
    Onuma Y, Kukreja N, Piazza N, Eindhoven J, Girasis C, Schenkeveld L, van Domburg R, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000 to 2007).
    J Am Coll Cardiol; 2009 Jul 14; 54(3):269-76. PubMed ID: 19589442
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials.
    Vardi M, Burke DA, Bangalore S, Pencina MJ, Mauri L, Kandzari DE, Leon MB, Cutlip DE.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):1031-8. PubMed ID: 23737390
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
    Romagnoli E, Leone AM, Burzotta F, Trani C, Angeloni G, Materazzo G, Niccoli G, De Vita M, Perfetti M, Mazzari MA, Mongiardo R, Rebuzzi AG, Schiavoni G, Crea F.
    J Cardiovasc Med (Hagerstown); 2008 Jun 01; 9(6):589-94. PubMed ID: 18475127
    [Abstract] [Full Text] [Related]

  • 19. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 20. "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry.
    Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schöbel WA, Sabin G, Senges J.
    Z Kardiol; 2004 Apr 25; 93(4):287-94. PubMed ID: 15085373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.